Modifying NICE’s approach to equity weighting

PharmacoEconomics

7 February 2021 - The UK’s NICE recently launched a consultation on the methods it uses to evaluate new health technologies, and has highlighted the issue of how ‘modifiers’, including equity weights, should be incorporated into its processes. 

The practice of applying equity weights to specific population subgroups, as a means for increasing the effective cost effectiveness threshold for some new health technologies, is well established in health technology assessment.

Read PharmacoEconomics article

Michael Wonder

Posted by:

Michael Wonder